二维剪切波弹性成像预测晚期慢性肝病生存
这项国际多中心回顾性队列研究纳入1827例晚期慢性肝病患者,开发了联合MELD评分与肝脏硬度(L-SWE)的M10LS20算法进行风险分层。高危组(L-SWE≥20 kPa且MELD≥10)2年死亡率和失代偿率分别为36.9%和61.8%,低危组分别为1.1%和3.5%,该算法经瞬时弹性成像和点剪切波弹性成像队列验证。
要点
- MELD联合L-SWE可独立预测晚期慢性肝病患者死亡(AUC 0.8)。
- L-SWE≥20 kPa且MELD≥10为高危,2年死亡率36.9%、失代偿率61.8%。
- 低危患者可延长随访间隔,高危患者需密切监测和强化治疗。
核心结论
- M10LS20算法(L-SWE≥20 kPa且MELD≥10)可对晚期慢性肝病患者进行风险分层,预测死亡和失代偿。
研究设计与样本
- 国际多中心回顾性队列研究,筛查16个中心2148例患者,最终纳入1827例有有效二维剪切波弹性成像结果的晚期慢性肝病患者(55岁,62.4%男性)。
主要发现
- 基线中位肝脏硬度(L-SWE)为11.8 kPa,MELD评分为8;MELD联合L-SWE独立预测死亡,AUC为0.8。
- 305例(18.3%)高危患者(L-SWE≥20 kPa且MELD≥10)2年死亡率和失代偿率分别为36.9%和61.8%。
- 944例(56.6%)低危患者2年死亡率和失代偿率分别为1.1%和3.5%。
- M10LS20算法经瞬时弹性成像测定的肝脏硬度及119例点剪切波弹性成像队列验证。
关键数值与推荐
- L-SWE≥20 kPa且MELD≥10定义为高危,建议密切随访和强化治疗。
- 低危患者可延长管理间隔。
临床怎么用
- 临床可联合MELD评分与二维剪切波弹性成像肝脏硬度(L-SWE)对晚期慢性肝病患者进行风险分层,高危者密切随访,低危者延长随访间隔。
局限性
- 本研究为回顾性研究,结论需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Liver stiffness measurement (LSM) is a tool used to screen for significant fibrosis and portal hypertension. The aim of this retrospective multicentre study was to develop an easy tool using LSM for clinical outcomes in advanced chronic liver disease (ACLD) patients. DESIGN: This international multicentre cohort study included a derivation ACLD patient cohort with valid two-dimensional shear wave elastography (2D-SWE) results. Clinical and laboratory parameters at baseline and during follow-up were recorded. LSM by transient elastography (TE) was also recorded if available. The primary outcome was overall mortality. The secondary outcome was the development of first/further decompensation. RESULTS: After screening 2148 patients (16 centres), 1827 patients (55 years, 62.4% men) were included in the 2D-SWE cohort, with median liver SWE (L-SWE) 11.8 kPa and a model for end stage liver disease (MELD) score of 8. Combination of MELD score and L-SWE predict independently of mortality (AUC 0.8). L-SWE cut-off at ≥20 kPa combined with MELD ≥10 could stratify the risk of mortality and first/further decompensation in ACLD patients. The 2-year mortality and decompensation rates were 36.9% and 61.8%, respectively, in the 305 (18.3%) high-risk patients (with L-SWE ≥20 kPa and MELD ≥10), while in the 944 (56.6%) low-risk patients, these were 1.1% and 3.5%, respectively. Importantly, this M10LS20 algorithm was validated by TE-based LSM and in an additional cohort of 119 patients with valid point shear SWE-LSM. CONCLUSION: The M10LS20 algorithm allows risk stratification of patients with ACLD. Patients with L-SWE ≥20 kPa and MELD ≥10 should be followed closely and receive intensified care, while patients with low risk may be managed at longer intervals.
引用
- Trebicka J, Gu W, de Ledinghen V, et al. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut. 2021. PMID: 33479052. doi:10.1136/gutjnl-2020-323419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。